Exciting updates from the Farhan lab

March 2022

The neurodegeneration genomics work by Dr. Allison Dilliott and Dr. Sali Farhan was highlighted for International Women's Day: 'From our lab to yours: empowering leadership through ONDRI'

September 2021

Welcome to our new Postdoctoral fellow, Dr. Allison Dilliott and to our new 4th year thesis student, Michael Fiorini!

May 2021

Welcome to our summer trainees: Lauren, Kate, Karina, Paul, and Anthony!

We're excited to announce that the Farhan lab received funding from the McGill initiative in Computational Medicine to support our gene enrichment projects and our collaborative project on the genomics of brain health with Dr. Danilo Bzdok!

March 2021

Check out the new preprint led by our collaborators in the Sadri-Vakili lab on the role of tau in ALS: 'Targeting tau mitigates mitochondrial fragmentation and oxidative stress in amyotrophic lateral sclerosis'

Our new collaborative paper is out where we evaluate the impact of three genetic variants in a patient with LMNA‑related lipodystrophy and amyotrophic lateral sclerosis. Read the paper 'Evidence of synergism among three genetic variants in a patient with LMNA‑related lipodystrophy and amyotrophic lateral sclerosis leading to a remarkable nuclear phenotype'

A New Faculty Spotlight on Dr. Sali Farhan can be found here. Read about our goals in advancing ALS genomics and working with clinicians to stratify patients with ALS to the appropriate clinical trial based on their genomic profile.

February 2021

Alongside a stellar team of neurodegeneration experts, Dr. Sali Farhan is a guest editor for the Frontiers in Neurology issue 'NeurOmics Technology: Advancing our Understanding of Neurodegenerative Diseases and Dementia'. Read about the topic here

The Farhan lab received an ALS Canada and Brain Canada Discovery Grant for the proposal "How does loss of normal function of DNAJC7 lead to ALS?" This is a collaboration with Dr. Martin Duennwald, Western University. You can read more about this announcement and other ALS initiatives here.

January 2021

Our new collaborative preprint is out assessing the role of MAPT (tau) in ALS. Read the preprint 'An in-depth analysis of phosphorylated tau in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid'




Back to top